Cosmos Group Holdings Inc. – OTC:COSG

Add to watchlist

+0.00

+100%

Market closed

Open in 1 day

-100.00%

month

-100.00%

quarter

-100.00%

year

Market Cap	6.32M
Enterprise value	3.18M

P/E	-0.04
EV/Sales	0.41
EV/EBITDA	-0.02
Price/Sales	0.50
Price/Book	0.26
PEG ratio	N/A
EPS	-0.04

Revenue	1.23M
EBITDA	-24.20M
Income	-78.47M
Revenue Q/Q	-100.27%
Revenue Y/Y	-90.87%

Profit margin	-1480.75%
Oper. margin	-1358.47%
Gross margin	123.33%
EBIT margin	-1358.47%
EBITDA margin	-1961.65%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Cosmos Group Holdings Inc. (OTC:COSG): Profit margin
Jun 2023	1.21M	-12.15M	-999.96%
Sep 2023	2.94K	-52.49M	-1780229.57%
Dec 2023	20.84K	-12.78M	-61345.12%
Mar 2024	-4.97K	-1.04M	20929.38%

Cosmos Group Holdings Inc. (OTC:COSG): Earnings per share (EPS)
2023-04-17	-0.04	-0.04

Cosmos Group Holdings Inc. (OTC:COSG): Debt to assets
Jun 2023	37387991	35.00M	93.62%
Sep 2023	19444846	53.62M	275.76%
Dec 2023	18654989	65.45M	350.86%
Mar 2024	17710057	64.72M	365.47%

Cosmos Group Holdings Inc. (OTC:COSG): Cash Flow
Jun 2023	551.20K	0	-370.74K
Sep 2023	-801.33K	10.10K	-1.04M
Dec 2023	951.31K	-489.98K	-486.35K
Mar 2024	-45.39K	0	61.10K

Cosmos Group Holdings alternative data

Cosmos Group Holdings
Employees

Cosmos Group Holdings Inc. (OTC:COSG): Employee count
Aug 2023	35
Sep 2023	35
Oct 2023	35
Nov 2023	35
Dec 2023	35
Jan 2024	35
Feb 2024	35
Mar 2024	35
Apr 2024	35
May 2024	35
Jun 2024	35
Jul 2024	35

Cosmos Group Holdings
Insider Trading

Cosmos Group Holdings Inc. (OTC:COSG): Insider trades (number of shares)
Period	Buy	Sel
Jul 2019	0	2149293
Jan 2020	0	1003732
Apr 2020	0	1718554

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	30 Apr 2020	CHEUNG KOON WING 10 percent owner 10 percent owner	Common Stock	215,369	$8.99	$1,936,167
Sale	30 Apr 2020	YIP TZE WAI ALBERT other: Chief Financial Officer other: Chief Financial Officer	Common Stock	1,503,185	$8.99	$13,513,633
Sale	16 Jan 2020	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	53,732	$8.99	$483,051
Sale	13 Jan 2020	CHEUNG KOON WING 10 percent owner 10 percent owner	Common Stock	950,000	$8.99	$8,540,500
Sale	19 Jul 2019	CHEUNG KOON WING 10 percent owner 10 percent owner	Common Stock	2,149,293	$8.99	$19,322,144
Sale	21 Sep 2018	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	32,585	$5.22	$170,094
Sale	10 Aug 2018	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	678,758	$3.21	$2,178,813
Sale	8 Aug 2018	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	7,188	$5.22	$37,521
Sale	3 Aug 2018	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	2,875	$5.22	$15,008
Sale	3 Aug 2018	WAN MIKY Y.C. director, 10 percent owner, officer: Preside.. director, 10 percent owner, off..	Common Stock	7,500	$5	$37,500

COSG insider trading transactions

Cosmos Group Holdings
Latest News

Thursday, 26 December 2024
13:30	Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology	accesswire.com
Monday, 23 December 2024
09:25	Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000	accesswire.com
Monday, 18 November 2024
08:00	Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets	accesswire.com
Friday, 15 November 2024
10:20	Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M	accesswire.com
Tuesday, 12 November 2024
12:00	Cosmos Health Issues Letter to Shareholders	accesswire.com
Friday, 1 November 2024
12:30	Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%	accesswire.com
Wednesday, 25 September 2024
09:25	Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands	accesswire.com
Monday, 23 September 2024
12:55	Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins	accesswire.com
09:00	Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits	accesswire.com
Thursday, 19 September 2024
15:40	Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion	accesswire.com
Wednesday, 18 September 2024
13:30	Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments	accesswire.com
Monday, 16 September 2024
08:30	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.	prnewswire.com
08:30	Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar	accesswire.com
Friday, 23 August 2024
09:35	Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements	accesswire.com
Wednesday, 21 August 2024
10:20	Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits	accesswire.com
Tuesday, 20 August 2024
12:20	Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs.	accesswire.com
09:00	Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit	accesswire.com
Thursday, 8 August 2024
13:00	Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market	accesswire.com
Tuesday, 6 August 2024
09:00	Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share	accesswire.com
Thursday, 25 July 2024
11:40	Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar	accesswire.com
Wednesday, 24 July 2024
10:55	Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity	accesswire.com
Thursday, 18 July 2024
15:45	Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units	accesswire.com
Wednesday, 10 July 2024
15:45	Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market	accesswire.com
Tuesday, 9 July 2024
14:00	Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually	accesswire.com
Monday, 1 July 2024
11:20	Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains	accesswire.com
Thursday, 27 June 2024
15:45	Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units	accesswire.com
Tuesday, 18 June 2024
10:00	Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent	accesswire.com
Thursday, 13 June 2024
09:25	Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million	accesswire.com
Friday, 17 May 2024
10:15	Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand	accesswire.com

Frequently Asked Questions (FAQ)

What's the price of Cosmos Group Holdings stock today?

One share of Cosmos Group Holdings stock can currently be purchased for approximately $0.
When is Cosmos Group Holdings's next earnings date?

Unfortunately, Cosmos Group Holdings's (COSG) next earnings date is currently unknown.
Does Cosmos Group Holdings pay dividends?

No, Cosmos Group Holdings does not pay dividends.
How much money does Cosmos Group Holdings make?

Cosmos Group Holdings has a market capitalization of 6.32M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 70.06% to 618.2K US dollars. Cosmos Group Holdings made a loss 77.34M US dollars in net income (profit) last year or -$0.04 on an earnings per share basis.
What is Cosmos Group Holdings's stock symbol?

Cosmos Group Holdings Inc. is traded on the OTC under the ticker symbol "COSG".
What is Cosmos Group Holdings's primary industry?

Company operates in the Financial Services sector and Credit Services industry.
How do i buy shares of Cosmos Group Holdings?

Shares of Cosmos Group Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Cosmos Group Holdings have?

As Jul 2024, Cosmos Group Holdings employs 35 workers.
When Cosmos Group Holdings went public?

Cosmos Group Holdings Inc. is publicly traded company for more then 26 years since IPO on 25 Mar 1999.
What is Cosmos Group Holdings's official website?

The official website for Cosmos Group Holdings is coinllectibles.art.

Cosmos Group Holdings Inc.

coinllectibles.art

Exchange:

OTC

Full time employees:

Industry:

Credit Services

Sector:

Financial Services

Cosmos Group Holdings Inc. offers financial and money lending services in Hong Kong and internationally. It also operates online platform for the sale and distribution of arts and collectibles. In addition, the company offers unsecured personal loans and mortgage loans to private individuals. The company is headquartered in Singapore.

, 048623

CIK: 0001706509
ISIN: US2214112003
CUSIP: 221411200